Locus Cell Co., Ltd. (TPEX:6891)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.00
-0.10 (-0.37%)
Mar 2, 2026, 1:23 PM CST
Market Cap5.42B +37.2%
Revenue (ttm)5.18M +397.7%
Net Income-164.24M
EPS-0.83
Shares Out200.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume156,070
Average Volume103,206
Open27.10
Previous Close27.10
Day's Range26.55 - 27.10
52-Week Range19.60 - 36.60
Beta0.56
RSI42.11
Earnings DateApr 16, 2026

About Locus Cell

Locus Cell Co., Ltd. focuses on contract development and manufacturing organization (CDMO) services for cell therapy related products in Taiwan and the United States. The company is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Yu-Hsiang Chang
Employees 53
Stock Exchange Taipei Exchange
Ticker Symbol 6891
Full Company Profile

Financial Performance

In 2024, Locus Cell's revenue was 2.36 million, an increase of 480.30% compared to the previous year's 406,000. Losses were -113.02 million, 16.6% more than in 2023.

Financial Statements